European Med Tech Market Access Services for Pharma
Your Preferred Specialized Vendor in Niche and Complex Area of Medical Devices
Recent news and posts
2025/26 National Genomic Test Directory released in England
On May 6, 2025, NHS England issued an updated version of the National Genomic Test Directory for 2025/26, which lists genomic tests commissioned by NHS England via Genomic Laboratory Hubs. Three documents were published specifying test codes, clinical indications, target genes, the technology by which tests are available, and eligibility criteria for patients:
- National Genomic Test Directory for cancer (version 12);
- National Genomic Test Directory for rare and inherited diseases (version 8);
- Rare and inherited disease eligibility criteria (version 8).
In the Test Directory for cancer, one new code (test-indication combination) was introduced related to liquid biopsy (ctDNA) in Non-Small Cell Lung Cancer (NSCLC):
- M4.14 Multi-target ctDNA combined Multi-target NGS panel - small variant (EGFR, ALK, BRAF, KRAS, MET exon 14 skipping and copy number variations) and structural variant (ROS1, RET, ALK, NTRK1, NTRK2, NTRK3, MET exon 14 skipping).
Furthermore, one new code (test-indication combination) was introduced for rare and inherited diseases.
See the full details here.
This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.